Page 342 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 342
Clinical Trials in Progress
P1309 A RANDOMIZED, OPEN-LABEL, MULTICENTER,
CONTROLLED STUDY TO ASSESS SAFETY AND EFFICACY
OF ELAD® HUMAN CELL-BASED BIO-ARTIFICIAL LIVER
SUPPORT SYSTEM (ELAD®) IN SUBJECTS WITH ALCOHOL-
INDUCED LIVER DECOMPENSATION (AILD)
Rob A. Ashley*, Jan Stange, Andrew J. Henry, Zheng Li, The United States
P1310 ADJUVANT CHEMOTHERAPY WITH GEMCITABINE
AND CISPLATIN COMPARED TO OBSERVATION
AFTER CURATIVE INTENT RESECTION OF
CHOLANGIOCARCINOMA AND MUSCLE INVASIVE
GALLBLADDER CARCINOMA (ACTICCA-1) - A
RANDOMIZED, MULTIDISCIPLINARY, MULTINATIONAL
PHASE III TRIAL
H Wege*, D Arnold, W O. Bechstein, J Bridgewater, D Goldstein,
L H. Jensen, S Kasper, H J. Klümpen, V Kunzmann, U Lindig,
A W. Lohse, B Nashan, J Primrose, M Rentsch, J Shannon, M Sinn,
K H. Weiss, A Stein, Germany
ePOSTERS YI P1311 THRIL; PILOT STUDY EVALUATING THE SAFETY AND
EFFICACY PROFILE OF REGULATORY T CELL THERAPY IN
LIVER TRANSPLANT RECIPIENTS
Gavin P. Whitehouse*, Niloufar Safinia, Irene Rebollo-Mesa, Katie Lowe,
Sarah Thirkell, Laura Fry, Alexandros Androulidakis, Marc Martinez-
Llordella, Andrew Hope, Varuna Aluvihare, Christopher Fisher,
Robert Lechler, Nigel Heaton, Giovanna Lombardi, Alberto Sanchez-
Fueyo, The United Kingdom
P1312 ALFAPUMP SYSTEM VERSUS TRANSJUGULAR
INTRAHEPATIC PORTOSYSTEMIC SHUNT AND
PARACENTESIS IN THE TREATMENT OF ASCITES. A
MULTICENTRE RANDOMISED CONTROLLED STUDY
(AGUA-TRIAL)
Cornelius Engelmann*, Oana Brosteanu, Hannelore Tenckhoff,
Jana Babatz, Frank Lammert, Michael Manns, Ingolf Schiefke,
Tony Bruns, Christian Trautwein, Stefan Zeuzem, Ulrich Treichel,
Rajiv Jalan, Thomas Berg, Germany
342 The International Liver Congress™ 2015 • ILC Programme
P1309 A RANDOMIZED, OPEN-LABEL, MULTICENTER,
CONTROLLED STUDY TO ASSESS SAFETY AND EFFICACY
OF ELAD® HUMAN CELL-BASED BIO-ARTIFICIAL LIVER
SUPPORT SYSTEM (ELAD®) IN SUBJECTS WITH ALCOHOL-
INDUCED LIVER DECOMPENSATION (AILD)
Rob A. Ashley*, Jan Stange, Andrew J. Henry, Zheng Li, The United States
P1310 ADJUVANT CHEMOTHERAPY WITH GEMCITABINE
AND CISPLATIN COMPARED TO OBSERVATION
AFTER CURATIVE INTENT RESECTION OF
CHOLANGIOCARCINOMA AND MUSCLE INVASIVE
GALLBLADDER CARCINOMA (ACTICCA-1) - A
RANDOMIZED, MULTIDISCIPLINARY, MULTINATIONAL
PHASE III TRIAL
H Wege*, D Arnold, W O. Bechstein, J Bridgewater, D Goldstein,
L H. Jensen, S Kasper, H J. Klümpen, V Kunzmann, U Lindig,
A W. Lohse, B Nashan, J Primrose, M Rentsch, J Shannon, M Sinn,
K H. Weiss, A Stein, Germany
ePOSTERS YI P1311 THRIL; PILOT STUDY EVALUATING THE SAFETY AND
EFFICACY PROFILE OF REGULATORY T CELL THERAPY IN
LIVER TRANSPLANT RECIPIENTS
Gavin P. Whitehouse*, Niloufar Safinia, Irene Rebollo-Mesa, Katie Lowe,
Sarah Thirkell, Laura Fry, Alexandros Androulidakis, Marc Martinez-
Llordella, Andrew Hope, Varuna Aluvihare, Christopher Fisher,
Robert Lechler, Nigel Heaton, Giovanna Lombardi, Alberto Sanchez-
Fueyo, The United Kingdom
P1312 ALFAPUMP SYSTEM VERSUS TRANSJUGULAR
INTRAHEPATIC PORTOSYSTEMIC SHUNT AND
PARACENTESIS IN THE TREATMENT OF ASCITES. A
MULTICENTRE RANDOMISED CONTROLLED STUDY
(AGUA-TRIAL)
Cornelius Engelmann*, Oana Brosteanu, Hannelore Tenckhoff,
Jana Babatz, Frank Lammert, Michael Manns, Ingolf Schiefke,
Tony Bruns, Christian Trautwein, Stefan Zeuzem, Ulrich Treichel,
Rajiv Jalan, Thomas Berg, Germany
342 The International Liver Congress™ 2015 • ILC Programme
